Related Experiment Video
Updated: Jun 10, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Benign myoclonic epilepsy of infancy evolving to Jeavons syndrome
Fettouma Moutaouakil1, Hicham El Otmani, Hicham Fadel
1Department of Neurology, Al Kortobi Hospital, Tangier, Morocco. mfettouma@hotmail.com
Insights
Benign myoclonic epilepsy of infancy can evolve into Jeavons syndrome, characterized by eyelid myoclonia and absences. This case highlights the need for extended monitoring in infants diagnosed with benign myoclonic epilepsy.
Area of Science:
- Neurology
- Epileptology
Background:
- Benign myoclonic epilepsy of infancy (BMEI) is a rare epileptic syndrome typically associated with a favorable prognosis.
- Recent evidence suggests BMEI may have less favorable outcomes than previously presumed.
Observation:
- A 14-year-old male with a history of infantile myoclonic seizures, diagnosed as BMEI, developed photosensitive eyelid myoclonia with absences (Jeavons syndrome) at age 10.
- The patient's initial infantile seizures were managed with valproate, and later eyelid myoclonia with absences was successfully treated with lamotrigine.
Findings:
- This case presents the second documented instance of BMEI evolving into Jeavons syndrome.
- The evolution suggests a potential continuum between these myoclonic epileptic syndromes.
Implications:
- Longer-term neurodevelopmental and seizure monitoring is crucial for patients diagnosed with BMEI.
- A common underlying genetic etiology may link BMEI and Jeavons syndrome, warranting further investigation.
Abstract:
Benign myoclonic epilepsy of infancy is a rare idiopathic generalized epileptic syndrome occurring below the age of 3 years. Although benign outcome is presumed, some recent studies suggest less favorable outcome. A 14-year-old boy had a history of repeated episodes of myoclonic jerks of the shoulders and upper limbs in infancy (age 5 months). An ictal electroencephalogram indicated generalized spike-wave discharges associated with the myoclonic seizures, and the diagnosis of benign myoclonic epilepsy of infancy was made. Valproate treatment resulted in control of the myoclonic seizures, and the drug was withdrawn when the patient was 5 years of age. At the age of 10, he presented with episodes of eyelid jerks associated with brief lapses in concentration triggered by sunlight. Electroencephalography revealed photosensitivity and a pattern of eye-closure sensitivity. These features were compatible with the diagnosis of eyelid myoclonia with absences, or Jeavons syndrome. Lamotrigine eliminated the seizures. The evolution of benign myoclonic epilepsy of infancy to eyelid myoclonia with absences has been reported in one other case. A possible continuum of myoclonic epileptic syndromes, mediated by a common genetic abnormality, suggests the need for longer monitoring of patients with benign myoclonic epilepsy of infancy.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types
Seizures l: Introduction
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
